Bakx Therapeutics

Developer of transformative cancer therapies

placeNew York City, New York, United States calendar_todayFounded 2020 groups7 employees language bakxtx.com

Innovation

1 patent family — focus: Chemistry & metallurgy; filing pace slowing. Cited 3 times.

YearFilings
20231

Investor mix

3 investors on record; lead investors include Sherpa Healthcare Partners.

Investor typeCountShare
Venture capital267%
Other / undisclosed133%
Coming soon